46 Biotech Startups in Paris to Watch in 2023
Paris's Biotech sector is booming. This year’s list of the best 46 Paris Biotech startups is an eclectic mix of hyper-growth scaleups, small creative startups and everything in between.
Last update: September 12, 2023
Featured companies in Company
Featured
Ultrasound-based medical device to treat a wide range of brain disorders.
-
Latest Funding
$41 Million · Series B
-
Employees
1 to 10
-
Investors
Panakes Partners, Panakes Partners, EIC Accelerator, EIC Accelerator
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Contact
•••••@carthera.eu
Unlock contact info
Featured
Mnemo Therapeutics specializes in biotechnology and life science.
-
Latest Funding
$90 Million · Series A
-
Employees
101 to 250
-
Investors
Sofinnova Partners
-
Business Model
B2B
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Contact
•••••@mnemo-tx.com
Unlock contact info
Featured
SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal di...
-
Latest Funding
$53 Million · Series A
-
Employees
1 to 10
-
Investors
Ysios Capital
-
Business Model
B2B
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Paris
-
Contact
•••••@sparingvision.com
Unlock contact info
Full list of Biotech startups in Paris
Automated bioprocessing system for the production of cell and gene therapies.
-
Latest Funding
$18 Million · Seed
-
Industries
Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Investors
AdBio Partners
-
Contact
•••••@astraveus.com
Unlock contact info
Medical devices for a transvascular treatment of pulmonary hypertension.
-
Latest Funding
$15 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
Sofinnova Partners, Asabys Partners
-
Contact
•••••@gradientdenervation.com
Unlock contact info
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
-
Latest Funding
$46 Million
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Bioqube Ventures
-
Contact
•••••@egle-tx.com
Unlock contact info
Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.
-
Latest Funding
$12 Million · Series B
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Pureos Bioventures, Karista
-
Contact
•••••@eyevensys.com
Unlock contact info
Petroleum-free pigments.
-
Latest Funding
$16 Million · Series A
-
Industries
Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Bpifrance, Elaia
-
Contact
•••••@pili.bio
Unlock contact info
Niodegradable sealants and adhesives for wound closure.
-
Latest Funding
$55 Million · Series D
-
Industries
Health Tech, Hardware, Biotech, Manufacturing
-
Locations
Paris
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Credit Mutuel, CM-CIC Capital Finance, Omnes Capital, Cathay Innovation, Sofinnova Partners, Bpifrance, Karista
-
Contact
•••••@tissium.com
Unlock contact info
AI-dirven clinical biology.
-
Latest Funding
$15 Million · Series A
-
Industries
Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Investors
Sofinnova Partners
-
Contact
•••••@kiro.bio
Unlock contact info
Interceptive therapies for heart failure subpopulations.
-
Latest Funding
$70 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
OrbiMed, Invivo Capital Partners, Omnes Capital
-
Contact
•••••@corteriapharma.com
Unlock contact info
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.
-
Latest Funding
$17 Million · Series B
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo, Norgine Ventures, Verve Ventures
-
Contact
•••••@pathoquest.com
Unlock contact info
Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
-
Latest Funding
$41 Million · Series B
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
AGORANOV, Bpifrance, Idinvest Partners, Hadean Ventures
-
Contact
•••••@step-ph.com
Unlock contact info
Protein-based vaccines.
-
Latest Funding
$7.8 Million · Series A
-
Industries
Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
In-Q-Tel
-
Contact
•••••@linkinvax.com
Unlock contact info
Gene therapies for rare diseases.
-
Latest Funding
$39 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Omnes Capital, Kurma Partners, Bpifrance, Idinvest Partners, V-Bio Ventures, Seroba Life Sciences
-
Contact
•••••@coavetx.com
Unlock contact info
Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.
-
Latest Funding
$43 Million · Series F
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Paris
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Omnes Capital, Nestlé Health Science, Seventure Partners
-
Contact
•••••@enterome.com
Unlock contact info
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.
-
Latest Funding
$6 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Fountain Healthcare Partners
-
Contact
•••••@ermium.com
Unlock contact info
We create sustainable cultivated meat delights for an uncompromising and conscious generation.
-
Latest Funding
$48 Million · Series A
-
Industries
Health Tech, Foodtech, Biotech, Deep Tech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, B2C
-
Investors
Thia Ventures, Partech Ventures, Heartcore, Air Street Capital, Point Nine Capital, Keen Venture Partners, Earlybird Venture Capital, Social Starts
-
Contact
•••••@gourmey.com
Unlock contact info
nextProtein develops a new large-scale technology that produces a sustainable source of protein.
-
Latest Funding
$11 Million · Series A
-
Industries
Climate Tech & Green Tech, Agritech, Foodtech, Biotech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Blue Oceans Partners
-
Contact
•••••@nextprotein.co
Unlock contact info
Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.
-
Latest Funding
$17 Million · Seed
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
XAnge, Quantonation
-
Contact
•••••@qubit-pharmaceuticals.com
Unlock contact info
Stilla Technologies is a Paris-based european biotechnology company.
-
Latest Funding
$13 Million
-
Industries
Health Tech, Biotech, Genetics
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo
-
Contact
•••••@stillatechnologies.com
Unlock contact info
Biomemory designs a low-cost, biobased solution for storing large amounts of computer data on long DNA strands.
-
Latest Funding
$5.2 Million
-
Industries
Health Tech, Biotech, Data and Analytics, Business Intelligence
-
Locations
Paris
-
Employees
1 to 10
-
Investors
Bpifrance
-
Contact
•••••@biomemory-labs.com
Unlock contact info
AI to detect congenital heart defects in fetuses.
-
Latest Funding
$2.1 Million · Seed
-
Industries
AI, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Investors
Sofinnova Partners
-
Contact
•••••@brightheart.fr
Unlock contact info
Drug discovery - Pharma 3.0
-
Latest Funding
$29 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma, Quantum Computing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Eurazeo, Elaia
-
Contact
•••••@aqemia.com
Unlock contact info
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.
-
Latest Funding
$11 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Thia Ventures, XAnge, Entrepreneur First, Plug and Play Spain
-
Contact
•••••@corebiogenesis.com
Unlock contact info
Faircraft is leveraging advanced synthetic biology and material science techniques to develop a lab-grown alternative to animal leather.
-
Latest Funding
$4.7 Million
-
Industries
Climate Tech & Green Tech, Fashion, Biotech, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Kindred Capital, Entrepreneur First
-
Contact
•••••@faircraft.bio
Unlock contact info
AI-powered data collecting tool for clinical trials.
-
Latest Funding
$20 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning, Pharma
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Cathay Innovation, Serena, Fly Ventures, Kima Ventures
-
Contact
•••••@inato.com
Unlock contact info
Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases
-
Latest Funding
$2.3 Million · Pre Seed
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Elaia
-
Contact
•••••@honing-biosciences.com
Unlock contact info
InnovaFeed is a biotech company producing insect-based protein for the feed industry.
-
Latest Funding
$250 Million · Series D
-
Industries
Biotech, Deep Tech
-
Locations
Paris
-
Employees
101 to 250
-
Contact
•••••@innovafeed.com
Unlock contact info
PLANT-BASED MARINE SUBSTITUTES WITH ALGAE INGREDIENTS. FOR NATURAL, HEALTHY, SUSTAINABLE FOOD
-
Latest Funding
$3.4 Million · Pre Seed
-
Industries
Agritech, Foodtech, Biotech, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B, B2C
-
Investors
Demeter Partners, Founders Future
-
Contact
•••••@seafood-reboot.com
Unlock contact info
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
-
Latest Funding
$10 Million · Seed
-
Industries
Health Tech, Biotech, Genetics, Business Intelligence
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Y Combinator
-
Contact
•••••@whitelabgx.com
Unlock contact info
Developing pinpoint gene therapy.
-
Latest Funding
$5.6 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2C
-
Contact
•••••@eg427.com
Unlock contact info
Topical treatments for complex pain.
-
Latest Funding
$21 Million · Series B
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
1 to 10
-
Contact
•••••@algotx.com
Unlock contact info
DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.
-
Latest Funding
$6 Million · Series A
-
Industries
Health Tech, AI, Biotech, Machine Learning
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Kima Ventures, Entrepreneur First
-
Contact
•••••@trydeeplife.org
Unlock contact info
Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.
-
Latest Funding
$35 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing, Genetics
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@depixus.com
Unlock contact info
Neoplants is a Biotechnology Company.
-
Latest Funding
$20 Million · Seed
-
Industries
Agritech, Biotech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Heartcore, Entrepreneur First, True Ventures
-
Contact
•••••@neoplants.co
Unlock contact info
InSpek develops a biological and chemical monitoring systems using integrated photonics.
-
Latest Funding
$570 Thousand · Pre Seed
-
Industries
Biotech, Data and Analytics, Robotics, Navigation and Mapping, Manufacturing, Business Intelligence
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Quantonation
-
Contact
•••••@inspek-solutions.com
Unlock contact info
DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.
-
Latest Funding
$5.7 Million · Series A
-
Industries
Health Tech, Hardware, Biotech, Business Intelligence
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Contact
•••••@damae-medical.com
Unlock contact info
EverImmune provides therapeutic tools related to cancer.
-
Latest Funding
$5.7 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@everimmune.com
Unlock contact info
BforCure is a biotech engaged in the manufacture of high speed biosensing solutions such as CHRONOS PCR.
-
Latest Funding
$5.5 Million
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@bforcure.com
Unlock contact info
Corlieve Therapeutics is a biotechnology company.
-
Industries
Health Tech, Biotech
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Pureos Bioventures
-
Contact
•••••@corlieve.com
Unlock contact info
Qynapse offers peace of mind by combining MRI scans and AI to produce rapid, actionable insights into central nervous system (CNS) disorders
-
Latest Funding
$2.8 Million · Seed
-
Industries
Health Tech, AI, Biotech, Deep Tech, Machine Learning, Data and Analytics
-
Locations
Paris
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Contact
•••••@qynapse.com
Unlock contact info
Alkion BioInnovations is a biotechnology company based in France.
-
Latest Funding
$640 Thousand · Seed
-
Industries
Health Tech, Foodtech, Biotech, Energy & Nuclear, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@alkinnov.com
Unlock contact info
Circul'Egg recycles the eggshells by transforming them into two finished products: a calcium carbonate powder and a shell membrane powder.
-
Latest Funding
$1.1 Million
-
Industries
Climate Tech & Green Tech, Agritech, Foodtech, Fashion, Biotech, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@circulegg.fr
Unlock contact info
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
-
Latest Funding
$1.4 Million
-
Industries
Health Tech, Biotech, Pharma
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@everzom.com
Unlock contact info
Sublime Energie provides transportation of biogas.
-
Latest Funding
$1.2 Million
-
Industries
Biotech, Mobility & Transportation, Energy & Nuclear, Manufacturing
-
Locations
Paris
-
Employees
1 to 10
-
Business Model
B2B
-
Contact
•••••@sublime-energie.com
Unlock contact info